{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:31:09Z","timestamp":1793781069224,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biocel.2026.107051","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:55:01Z","timestamp":1791993301000},"page":"107051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CUX1 modified by m6A methylation drives benign prostatic hyperplasia via the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1016","volume":"201","author":[{"given":"Feng","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6637-2522","authenticated-orcid":false,"given":"Zhangming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2026.107051_bib1","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/bloodadvances.2018028423","article-title":"Distinct clinical and biological implications of CUX1 in myeloid neoplasms","volume":"3","author":"Aly","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.biocel.2026.107051_bib2","doi-asserted-by":"crossref","first-page":"14786","DOI":"10.1021\/acs.jmedchem.4c01247","article-title":"Methyl-transferase-like protein 16 (METTL16): the intriguing journey of a key epitranscriptomic player becoming an emerging biological target","volume":"67","author":"Barone","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biocel.2026.107051_bib3","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.7150\/thno.99019","article-title":"The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases","volume":"14","author":"Bu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.biocel.2026.107051_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00297-16","article-title":"Targeting the nuclear Cathepsin L CCAAT displacement protein\/cut homeobox transcription factor-epithelial mesenchymal transition pathway in prostate and breast cancer cells with the Z-FY-CHO inhibitor","volume":"37","author":"Burton","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biocel.2026.107051_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(08)02617-7","article-title":"Messenger RNA half-life measurements in mammalian cells","volume":"448","author":"Chen","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biocel.2026.107051_bib6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s42003-024-07071-y","article-title":"Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist","volume":"7","author":"Cooper","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biocel.2026.107051_bib7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.18632\/oncotarget.27494","article-title":"The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer","volume":"11","author":"Dorris","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.biocel.2026.107051_bib8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00345-019-02691-0","article-title":"What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?","volume":"37","author":"Foo","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.biocel.2026.107051_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102462","article-title":"CUX1 enhances pancreatic cancer formation by synergizing with KRAS and inducing MEK\/ERK-dependent proliferation","volume":"13","author":"Griesmann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biocel.2026.107051_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2012.01.039","article-title":"CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases","volume":"497","author":"Hulea","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.biocel.2026.107051_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41419-022-05162-4","article-title":"METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m(6)A-YTHDF2-dependent manner","volume":"13","author":"Li","year":"2022","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.biocel.2026.107051_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12964-024-01644-4","article-title":"Aberrant activation of TGF-\u03b2\/ROCK1 enhances stemness during prostatic stromal hyperplasia","volume":"22","author":"Li","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.biocel.2026.107051_bib13","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-020-15913-6","article-title":"Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2026.107051_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110933","article-title":"STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia","volume":"113","author":"Liu","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biocel.2026.107051_bib15","first-page":"263","article-title":"The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression","volume":"42","author":"Liu","year":"2023","journal-title":"Journal experimental & clinical cancer research CR"},{"key":"10.1016\/j.biocel.2026.107051_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21037\/tau.2019.10.01","article-title":"Epidemiology and treatment modalities for the management of benign prostatic hyperplasia","volume":"8","author":"Lokeshwar","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.biocel.2026.107051_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biocel.2026.107051_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164219","article-title":"The curious case of tryptophan in pregnancy","volume":"132","author":"Marsden","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2026.107051_bib19","first-page":"843","article-title":"Current treatment for benign prostatic hyperplasia","volume":"117","author":"Miernik","year":"2020","journal-title":"Dtsch Arztebl Int."},{"key":"10.1016\/j.biocel.2026.107051_bib20","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1109\/TCBB.2022.3233670","article-title":"Brute force virtual drug screening with molecular dynamics simulation and MM\/PBSA to find potent inhibitors of METTL16","volume":"20","author":"Mitra","year":"2023","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform"},{"key":"10.1016\/j.biocel.2026.107051_bib21","first-page":"S141","article-title":"BPH: costs and treatment outcomes","volume":"12","author":"Nickel","year":"2006","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.biocel.2026.107051_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40364-024-00657-y","article-title":"Oncogenic ACSM6 impairs CD8(+) T cell-based immune response in bladder cancer","volume":"12","author":"Nie","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.biocel.2026.107051_bib23","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2026.107051_bib24","article-title":"RNA methylation in urological cancers: regulatory logic, biological functions, and clinical relevance","volume":"17","author":"Peng","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2026.107051_bib25","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","article-title":"Role of m6A RNA methylation in cardiovascular disease (Review)","volume":"46","author":"Qin","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biocel.2026.107051_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/gut.2009.189720","article-title":"CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer","volume":"59","author":"Ripka","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.biocel.2026.107051_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.gene.2008.01.017","article-title":"The multiple roles of CUX1: insights from mouse models and cell-based assays","volume":"412","author":"Sansregret","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.biocel.2026.107051_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/13685538.2018.1519014","article-title":"Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia","volume":"23","author":"Sreenivasulu","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.biocel.2026.107051_bib29","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2026.107051_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7958316","article-title":"Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia","volume":"2020","author":"Tong","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biocel.2026.107051_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20230574","article-title":"RNA m6A modification, signals for degradation or stabilisation?","volume":"52","author":"Wei","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biocel.2026.107051_bib32","article-title":"The emerging role of m(6)A methylation in prostate-related diseases: mechanisms and clinical implications","volume":"17","author":"Xie","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2026.107051_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/md22060275","article-title":"Avellanin a has an antiproliferative effect on TP-induced RWPE-1 cells via the PI3K-Akt signalling pathway","volume":"22","author":"Xu","year":"2024","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.biocel.2026.107051_bib34","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1097\/JS9.0000000000002116","article-title":"METTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression - experimental studies","volume":"110","author":"Yi","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.biocel.2026.107051_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12882-024-03625-8","article-title":"CUX1 attenuates the apoptosis of renal tubular epithelial cells induced by contrast media through activating the PI3K\/AKT signaling pathway","volume":"25","author":"Yue","year":"2024","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.biocel.2026.107051_bib36","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3389\/fimmu.2019.00922","article-title":"A review in research progress concerning m6A methylation and immunoregulation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2026.107051_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.21037\/tau-23-682","article-title":"METTL14 inhibits the proliferation, migration and invasion of prostate cancer cells by increasing m6A methylation of CDK4","volume":"13","author":"Zhong","year":"2024","journal-title":"Transl. Androl. Urol."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:06:46Z","timestamp":1793779606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272526001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S1357272526001615"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2026.107051","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CUX1 modified by m6A methylation drives benign prostatic hyperplasia via the PI3K\/AKT\/mTOR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2026.107051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107051"}}